- ASSOCIATE PROFESSOR Genetics and Genomic Sciences
- ASSOCIATE PROFESSOR Medicine
American Board of Internal Medicine
MBBS, Topiwala National Medical College
Master's, University of Pittsburgh
Residency, Internal Medicine
North Shore Univ. Hosp. at Forest Hills
Fellowship, Medical Genetics
Mount Sinai Hospital
Fellowship, Biochemical Genetics
Mount Sinai Hospital
- Board Certification: Internal Medicine, Clinical Genetics
ResearchCurrent Research: Modifier Genes in Type I Gaucher disease
Balwani M, Smukler L, Edelmann L, Kornreich R, Desnick RJ. Type 1 Gaucher Disease: Significant Disease manifestations in “asymptomatic homozygotes” . Arch. Inter. Med;.
Cantatore-Francis JL, Cohen J, Balwani M, Desnick RJ, Schaffer JV. Hepatoerythropoietic Porphyria misdiagnosed as child abuse: cutaneous and hematologic manifestations in siblings with a novel UROD mutation. Arch. Dermatol.;.
Balwani M, Fuerstman L, Desnick RJ, Buckley B, McGovern MM. Use of complimentary and alternative medicine by patients with lysosomal storage diseases. Genet. Med 2009; 11(722-727).
Hermann G, Simpson WL, Balwani M. A Gaucher-kor manifesztacioi a csontrendszerben (The manifesations of Gaucher disease in the skeletal system).. Osteologiai Kozlemenyek (Skeletal Radiology) 2008; 3(121-128).
Carreiro J, Balwani M, Grosskreutz C, Isola L, Malone A, Scigliano E, Osman K. A case report of secondary autograft failure due to Gaucher disease. Am. J. Hematol 2008; 83(937).
Grace ME, Balwani M, Nazarenko I, Prakash-Cheng A, Desnick RJ. Type I Gaucher Disease: null and hypomorphic novel chitotriosidase gene mutations- implications for diagnosis and therapeutic monitoring. . Hum. Mut. 2007; 28(28:866-873).
Sansaricq C, Pardo S, Balwani M, Grace M, Raymond K. Biochemical and molecular diagnosis of lipoamide dehydrogenase deficiency in a North American Ashkenazi Jewish family. . J. Inherit. Metabol. Dis. 2006; 29(203-204).
Anderson KE, Lee C, Balwani M, Desnick RJ. Porphyrias. In: Nelson Textbook of Pediatrics, Behrman, R.E., Kleigman, R.M. and Jenson, H.B., Eds., . W.B. Saunders Company, Philadelphia;(19).
Balwani M, Prakash-Cheng A, Desnick RJ. Encyclopedia of Molecular Mechanisms of Disease, F. Lange, Ed., . Springer-Verlag GmbH Heidelberg, Germany, pp 2009;(691-692).
Sansaricq C, Balwani M. Essential Pediatric Endocrinology and Inborn Errors of Metabolism. Kyriakie Sarafoglou, McGraw Hill 2008;.
- A Phase 1, Single-Ascending Dose, Multiple-Ascending Dose, and Multi-Dose Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Subcutaneously Administered Aln-As1 in Patients with Acute Intermittent Porphyria (AIP)
- Clinical and Molecular Studies of the Erythropoietic Protoporphyria Phenotype
- Gaucher Registry
- Natural History Study of Acute Hepatic Porphyria (AHP) with Recurrent Attacks
- Premotor Signs and Symptoms of Parkinsonism in Non-Manifesting GBA Mutation Carriers
- Natural History and Treatment of Gaucher Disease
- Survey Study of the Prevalence of Parkinson Disease in Patients and Families with Gaucher Disease
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Balwani during 2015 and/or 2016. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Alexion Pharmaceuticals, Inc.; Genzyme Corporation; Recordati Rare Diseases, Inc. (RRD); Shire; Synageva BioPharma
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Genzyme Corporation
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- Alexion Pharmaceuticals, Inc.; Alnylam Pharmaceuticals
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Atran Berg Laboratory Building Floor 1st Floor, Room AB1-50
1428 Madison Avenue
New York, NY 10029
1184 Fifth Avenue, 2nd Floor
Gaucher and Porphyria Disease patients only
New York, NY 10029
- Tuesday 9:00am - 4:00pm
- Wednesday 9:00am - 4:00pm
- Thursday 9:00am - 4:00pm
- Friday 9:00am - 12:00pm